Alexander Egle (A Egle)

ORCID

Publication Activity (10 Years)

Years Active: 2015-2024
Publications (10 Years): 23

Top Venues

American journal of hematology

Leukemia

Cancers

EJHaem

This page only lists publications with an associated author ORCID identifier.

Publications

Heinz Ludwig, Thomas Melchardt, Siegfried Sormann, Martin Schreder, Johannes Andel, Bernd Hartmann, Christoph Tinchon, Niklas Zojer, Eberhard Gunsilius, Klaus Podar, Alexander Egle, Wolfgang Willenbacher, Ewald Wöll, Reinhard Ruckser, Boris Bozic, Maria-Theresa Krauth, Andreas Petzer, Clemens Schmitt, Sigrid Machherndl-Spandl, Hermine Agis, Michael Fillitz, Song-Yau Wang, August Zabernigg, Stefan Knop, Bruno Paiva, Richard Greil
Randomized comparison between KTd and KRd induction therapy followed by maintenance therapy with K or observation in transplant-ineligible patients with newly diagnosed multiple myeloma. American journal of hematology (2024)
Heinz Ludwig, Thomas Melchardt, Ilvy Schweitzer, Siegfried Sormann, Martin Schreder, Johannes Andel, Bernd Hartmann, Niklas Zojer, Laurenz Schöffmann, Eberhard Gunsilius, Klaus Podar, Alexander Egle, Wolfgang Willenbacher, Ewald Wöll, Reinhard Ruckser, Boris Bozic, Maria-Theresa Krauth, Andreas Petzer, Clemens Schmitt, Sigrid Machherndl-Spandl, Hermine Agis, Michael Fillitz, Song-Yau Wang, Stefan Knop, Richard Greil
QoL during KTd or KRd induction followed by K maintenance or observation in transplant noneligible patients with newly diagnosed multiple myeloma: Longitudinal and cross-sectional analysis of the randomized AGMT 02 study. EJHaem 5 (3) (2024)
Heinz Ludwig, Thomas Melchardt, Siegfried Sormann, Martin Schreder, Johannes Andel, Bernd Hartmann, Christoph Tinchon, Niklas Zojer, Eberhard Gunsilius, Klaus Podar, Alexander Egle, Wolfgang Willenbacher, Ewald Wöll, Reinhard Ruckser, Boris Bozic, Maria-Theresa Krauth, Andreas Petzer, Clemens Schmitt, Sigrid Machherndl-Spandl, Hermine Agis, Michael Fillitz, Song-Yau Wang, August Zabernigg, Stefan Knop, Bruno Paiva, Richard Greil
Randomized comparison between KTd and KRd induction therapy followed by maintenance therapy with K or observation in transplant-ineligible patients with newly diagnosed multiple myeloma. American journal of hematology 99 (5) (2024)
Heinz Ludwig, Thomas Melchardt, Siegfried Sormann, Martin Schreder, Johannes Andel, Bernd Hartmann, Christoph Tinchon, Niklas Zojer, Eberhard Gunsilius, Klaus Podar, Alexander Egle, Wolfgang Willenbacher, Ewald Wöll, Reinhard Ruckser, Boris Bozic, Maria-Theresa Krauth, Andreas Petzer, Clemens Schmitt, Sigrid Machherndl-Spandl, Hermine Agis, Michael Fillitz, Song-Yau Wang, August Zabernigg, Stefan Knop, Bruno Paiva, Richard Greil
Randomized comparison between KTd and KRd induction therapy followed by maintenance therapy with K or observation in transplant-ineligible patients with newly diagnosed multiple myeloma. American journal of hematology 99 (5) (2024)
Heinz Ludwig, Thomas Melchardt, Siegfried Sormann, Martin Schreder, Johannes Andel, Bernd Hartmann, Christoph Tinchon, Niklas Zojer, Eberhard Gunsilius, Klaus Podar, Alexander Egle, Wolfgang Willenbacher, Ewald Wöll, Reinhard Ruckser, Boris Bozic, Maria-Theresa Krauth, Andreas Petzer, Clemens Schmitt, Sigrid Machherndl-Spandl, Hermine Agis, Michael Fillitz, Song-Yau Wang, August Zabernigg, Stefan Knop, Bruno Paiva, Richard Greil
Randomized comparison between KTd and KRd induction therapy followed by maintenance therapy with K or observation in transplant-ineligible patients with newly diagnosed multiple myeloma. American journal of hematology 99 (5) (2024)
Heinz Ludwig, Thomas Melchardt, Ilvy Schweitzer, Siegfried Sormann, Martin Schreder, Johannes Andel, Bernd Hartmann, Niklas Zojer, Laurenz Schöffmann, Eberhard Gunsilius, Klaus Podar, Alexander Egle, Wolfgang Willenbacher, Ewald Wöll, Reinhard Ruckser, Boris Bozic, Maria-Theresa Krauth, Andreas Petzer, Clemens Schmitt, Sigrid Machherndl-Spandl, Hermine Agis, Michael Fillitz, Song-Yau Wang, Stefan Knop, Richard Greil
QoL during KTd or KRd induction followed by K maintenance or observation in transplant noneligible patients with newly diagnosed multiple myeloma: Longitudinal and cross-sectional analysis of the randomized AGMT 02 study. EJHaem 5 (3) (2024)
Heinz Ludwig, Thomas Melchardt, Siegfried Sormann, Martin Schreder, Johannes Andel, Bernd Hartmann, Christoph Tinchon, Niklas Zojer, Eberhard Gunsilius, Klaus Podar, Alexander Egle, Wolfgang Willenbacher, Ewald Wöll, Reinhard Ruckser, Boris Bozic, Maria-Theresa Krauth, Andreas Petzer, Clemens Schmitt, Sigrid Machherndl-Spandl, Hermine Agis, Michael Fillitz, Song-Yau Wang, August Zabernigg, Stefan Knop, Bruno Paiva, Richard Greil
Randomized comparison between KTd and KRd induction therapy followed by maintenance therapy with K or observation in transplant-ineligible patients with newly diagnosed multiple myeloma. American journal of hematology 99 (5) (2024)
Bettina Jansko-Gadermeir, Michael Leisch, Franz Josef Gassner, Nadja Zaborsky, Thomas Dillinger, Sonja Hutter, Angela Risch, Thomas Melchardt, Alexander Egle, Manuel Drost, Julian Larcher-Senn, Richard Greil, Lisa Pleyer
Myeloid NGS Analyses of Paired Samples from Bone Marrow and Peripheral Blood Yield Concordant Results: A Prospective Cohort Analysis of the AGMT Study Group. Cancers 15 (8) (2023)
Bettina Jansko-Gadermeir, Michael Leisch, Franz Josef Gassner, Nadja Zaborsky, Thomas Dillinger, Sonja Hutter, Angela Risch, Thomas Melchardt, Alexander Egle, Manuel Drost, Julian Larcher-Senn, Richard Greil, Lisa Pleyer
Myeloid NGS Analyses of Paired Samples from Bone Marrow and Peripheral Blood Yield Concordant Results: A Prospective Cohort Analysis of the AGMT Study Group. Cancers 15 (8) (2023)
Barbara Altendorfer, Michael Stefan Unger, Rodolphe Poupardin, Anna Hoog, Daniela Asslaber, Iris Karina Gratz, Heike Mrowetz, Ariane Benedetti, Diana Marisa Bessa de Sousa, Richard Greil, Alexander Egle, David Gate, Tony Wyss-Coray, Ludwig Aigner
Transcriptomic Profiling Identifies CD8 + T Cells in the Brain of Aged and Alzheimer's Disease Transgenic Mice as Tissue-Resident Memory T Cells. Journal of immunology (Baltimore, Md. : 1950) 209 (7) (2022)
Dominik Kiem, Michael Leisch, Daniel Neureiter, Theresa Haslauer, Alexander Egle, Thomas Melchardt, Max S Topp, Richard Greil
Two Cases of Pancytopenia with Coombs-Negative Hemolytic Anemia after Chimeric Antigen Receptor T-Cell Therapy. International journal of molecular sciences 22 (11) (2021)
Eugene Park, Jingyu Chen, Andrew Moore, Maurizio Mangolini, Antonella Santoro, Joseph R Boyd, Hilde Schjerven, Veronika Ecker, Maike Buchner, James C Williamson, Paul J Lehner, Luca Gasparoli, Owen Williams, Johannes Bloehdorn, Stephan Stilgenbauer, Michael Leitges, Alexander Egle, Marc Schmidt-Supprian, Seth E Frietze, Ingo Ringshausen
Stromal cell protein kinase C-β inhibition enhances chemosensitivity in B cell malignancies and overcomes drug resistance. Science translational medicine 12 (526) (2021)
William G Wierda, Andrew Rawstron, Florence Cymbalista, Xavier Badoux, Davide Rossi, Jennifer R Brown, Alexander Egle, Virginia Abello, Eduardo Cervera Ceballos, Yair Herishanu, Stephen P Mulligan, Carsten Utoft Niemann, Colin P Diong, Teoman Soysal, Ritsuro Suzuki, Hoa T T Tran, Shang-Ju Wu, Carolyn Owen, Stephan Stilgenbauer, Paolo Ghia, Peter Hillmen
Measurable residual disease in chronic lymphocytic leukemia: expert review and consensus recommendations. Leukemia 35 (11) (2021)
Maria Schubert, Franz Josef Gassner, Michael Huemer, Jan Philip Höpner, Ekaterina Akimova, Markus Steiner, Alexander Egle, Richard Greil, Nadja Zaborsky, Roland Geisberger
AID Contributes to Accelerated Disease Progression in the TCL1 Mouse Transplant Model for CLL. Cancers 13 (11) (2021)
Heinz Ludwig, Bela Hausmann, Martin Schreder, Wolfram Pönisch, Niklas Zojer, Stefan Knop, Eberhard Gunsilius, Alexander Egle, Andreas Petzer, Hermann Einsele, Roman Hájek, Katja Weisel, Karl Jochen Krenosz, Alois Lang, Daniel Lechner, Richard Greil, David Berry
Reduced alpha diversity of the oral microbiome correlates with short progression-free survival in patients with relapsed/refractory multiple myeloma treated with ixazomib-based therapy (AGMT MM 1, phase II trial). EJHaem 2 (1) (2020)
Eva Szenes, Andrea Härzschel, Sarah Decker, Erika Tissino, Justine Pischeli, Julia Christine Gutjahr, Sandra Kissel, Sandra Pennisi, Jan Philip Höpner, Alexander Egle, Nadja Zaborsky, Christine Dierks, Marie Follo, Alexandre Chigaev, Antonella Zucchetto, Richard Greil, Valter Gattei, Tanja Nicole Hartmann
TCL1 transgenic mice as a model for CD49d-high chronic lymphocytic leukemia. Leukemia 34 (9) (2020)
Franz Josef Gassner, Nadja Zaborsky, Ilana Buchumenski, Erez Y Levanon, Matthias Gatterbauer, Maria Schubert, Stefanie Rauscher, Daniel Hebenstreit, Ferran Nadeu, Elias Campo, Alexander Egle, Richard Greil, Roland Geisberger
RNA editing contributes to epitranscriptome diversity in chronic lymphocytic leukemia. Leukemia 35 (4) (2020)
Alexander Egle, Thomas Melchardt, Petra Obrtlíková, Lukáš Smolej, Tomáš Kozák, Michael Steurer, Johannes Andel, Sonja Burgstaller, Eva Mikušková, Liana Gercheva, Thomas Nösslinger, Tomáš Papajík, Miriam Ladická, Michael Girschikofsky, Mikuláš Hrubiško, Ulrich Jäger, Daniela Voskova, Martin Pecherstorfer, Eva Králiková, Christina Burcoveanu, Emil Spasov, Andreas Petzer, Georgi Mihaylov, Julian Raynov, Horst Oexle, August Zabernigg, Emília Flochová, Stanislav Palášthy, Olga Stehlíková, Michael Doubek, Petra Altenhofer, Lukas Weiss, Teresa Magnes, Lisa Pleyer, Anton Klingler, Jiří Mayer, Richard Greil
Rituximab maintenance overcomes the negative prognostic factor of obesity in CLL: Subgroup analysis of the international randomized AGMT CLL-8a mabtenance trial. Cancer medicine 8 (4) (2019)
Daniela Asslaber, Nathalie Wacht, Michael Leisch, Yuan Qi, Nicole Maeding, Clemens Hufnagl, Bettina Jansko, Nadja Zaborsky, Andreas Villunger, Tanja N Hartmann, Richard Greil, Alexander Egle
BIRC3 Expression Predicts CLL Progression and Defines Treatment Sensitivity via Enhanced NF-κB Nuclear Translocation. Clinical cancer research : an official journal of the American Association for Cancer Research 25 (6) (2018)
Nadja Zaborsky, Franz J Gassner, Jan P Höpner, Maria Schubert, Daniel Hebenstreit, Richard Stark, Daniela Asslaber, Markus Steiner, Roland Geisberger, Richard Greil, Alexander Egle
Exome sequencing of the TCL1 mouse model for CLL reveals genetic heterogeneity and dynamics during disease development. Leukemia 33 (4) (2018)
Teresa Magnes, T Melchardt, C Hufnagl, L Weiss, C Mittermair, D Neureiter, E Klieser, G Rinnerthaler, S Roesch, A Gaggl, R Greil, Alexander Egle
The influence of FCGR2A and FCGR3A polymorphisms on the survival of patients with recurrent or metastatic squamous cell head and neck cancer treated with cetuximab. The pharmacogenomics journal 18 (3) (2017)
Alexander Egle
Milestones in Chronic Lymphocytic Leukemia: An exciting decade of progress-10th anniversary of memo. Memo 10 (1) (2017)
L Kazianka, C Drucker, C Skrabs, W Thomas, T Melchardt, S Struve, M Bergmann, P B Staber, E Porpaczy, C Einberger, M Heinz, A Hauswirth, M Raderer, I Pabinger, R Thalhammer, Alexander Egle, C-M Wendtner, G Follows, G Hoermann, P Quehenberger, B Jilma, U Jaeger
Ristocetin-induced platelet aggregation for monitoring of bleeding tendency in CLL treated with ibrutinib. Leukemia 31 (5) (2016)
Alexander Egle
Old and new news in CLL: "It's the pathway, stupid!". Blood 124 (7) (2015)

Alexander Egle.css-eqlu8i{font-size:small;padding-left:4px;} (A Egle)

Publication Activity (10 Years)

Top Topics

Top Venues

Alexander Egle (A Egle)